Mesoblast Ltd Files Appendix 3H with ASX
Ticker: MEOBF · Form: 6-K · Filed: Apr 17, 2024 · CIK: 1345099
| Field | Detail |
|---|---|
| Company | Mesoblast LTD (MEOBF) |
| Form Type | 6-K |
| Filed Date | Apr 17, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: securities-cessation, disclosure, ASX
Related Tickers: MESO
TL;DR
MESO files Appendix 3H with ASX - securities cessation. Check your holdings.
AI Summary
On April 15, 2024, Mesoblast Limited filed an Appendix 3H with the Australian Securities Exchange, announcing the cessation of securities. This filing is in accordance with their reporting obligations as a foreign private issuer.
Why It Matters
This filing indicates a change in the company's securities structure, which could impact investors' understanding of their shareholdings and potential dilution.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of securities cessation, not indicating immediate financial distress or significant operational changes.
Key Players & Entities
- Mesoblast Limited (company) — Registrant
- Silviu Itescu (person) — Chief Executive Officer and Executive Director
- Australian Securities Exchange (company) — Filing recipient
- April 15, 2024 (date) — Filing date
- Appendix 3H (document) — Filed document
FAQ
What is the specific reason for the cessation of securities announced in the Appendix 3H?
The provided filing does not specify the exact reason for the cessation of securities, only that an Appendix 3H was filed with the Australian Securities Exchange on April 15, 2024, announcing this cessation.
What type of securities are ceasing, and what is the impact on outstanding shares?
The filing does not detail the specific types of securities ceasing or their impact on the total number of outstanding shares.
Is this cessation related to a corporate action, such as a buyback or delisting?
The filing does not provide information to confirm if the cessation is related to a corporate action like a buyback or delisting.
When will the cessation of these securities become effective?
The filing does not state the effective date of the securities cessation.
Where can investors find more detailed information about this securities cessation?
Investors can refer to the Appendix 3H filed by Mesoblast Limited with the Australian Securities Exchange on April 15, 2024, for more details, though the provided 6-K only announces its filing.
Filing Stats: 219 words · 1 min read · ~1 pages · Grade level 18.3 · Accepted 2024-04-16 21:17:39
Filing Documents
- form6-kxpressreleasecoverf.htm (6-K) — 20KB
- exhibit991appendix3h-not.htm (EX-99.1) — 5KB
- exhibit991appendix3h-not001.jpg (GRAPHIC) — 79KB
- exhibit991appendix3h-not002.jpg (GRAPHIC) — 57KB
- exhibit991appendix3h-not003.jpg (GRAPHIC) — 76KB
- exhibit991appendix3h-not004.jpg (GRAPHIC) — 118KB
- 0001345099-24-000035.txt ( ) — 480KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly organized. Mesoblast Limited s Niva Sivakumar Niva Sivakumar Company Secretary Dated April 17, 2024 INDEX TO EXHIBITS Item 99.1 Appendix 3H of Mesoblast Ltd, dated April 15, 2024